Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus

Weng,Hui; Liu,Hongbo; Deng,Yunhua; Xie,Yuyan; Shen,Guanxin

doi:10.3892/mmr.2014.2477

Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus

Authors:
- Hui Weng
- Hongbo Liu
- Yunhua Deng
- Yuyan Xie
- Guanxin Shen
View Affiliations

Affiliations: Department of Dermatology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, P.R. China, Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Pathology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, P.R. China
Published online on: August 11, 2014 https://doi.org/10.3892/mmr.2014.2477
Pages: 1765-1771
Copyright: © Weng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Accumulative evidence has demonstrated that inflammation has an important role in human papillomavirus (HPV) oncogenicity. However, the effects of high mobility group protein box 1 (HMGB1)-toll like receptor 4 (TLR4) signaling pathway associated inflammation on epidermal warts caused by HPV remain unclear. The present study investigated the HMGB1, TLR4 and nuclear factor-κB p65 expression in condyloma acuminatum (CA) and verruca vulgaris (VV). Immunohistochemistry and western blot analysis revealed that p65 expression in epithelial nuclei in VV and CA was significantly higher than in normal skin (NS) (P<0.01), and p65 in CA was higher than in VV but this difference was not significant. The level of extracellular HMGB1 increased significantly and progressively from NS to VV to CA (P<0.05). The level of TLR4 on the surface of epithelial membranes in the CA samples was significantly higher than in NS (P<0.01), and TLR4 in VV samples was significantly lower than in NS (P<0.01). There was a positive correlation between p65 expression in the epithelial nuclei and HMGB1 in the epithelial intercellular spaces (r=0.5199, P<0.01). These findings indicate that inflammation is intensified in warts caused by HPV. HMGB1-TLR4 pathway‑associated inflammation may therefore have a pivotal role in CA. HMGB1, rather than TLR4, may be a vital mediator of inflammation in VV. Therapies targeting HMGB1 may be a potential strategy for the treatment of HPV-associated warts.

View Figures

View References

1	Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H and de Villiers EM: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 401:70–79. 2010. View Article : Google Scholar : PubMed/NCBI
2	Stanley MA, Pett MR and Coleman N: HPV: from infection to cancer. Biochem Soc Trans. 35:1456–1460. 2007. View Article : Google Scholar : PubMed/NCBI
3	Aggarwal BB, Shishodia S, Sandur SK, Pandey MK and Sethi G: Inflammation and cancer: how hot is the link? Biochem Pharmacol. 72:1605–1621. 2006. View Article : Google Scholar : PubMed/NCBI
4	Balkwill F and Coussens LM: Cancer: an inflammatory link. Nature. 431:405–406. 2004. View Article : Google Scholar
5	Thomas JO and Travers AA: HMG1 and 2, and related ‘architectural’ DNA-binding proteins. Trends Biochem Sci. 26:167–174. 2001.
6	Tadie J, Bae HB, Deshane J, et al: Toll-like receptor 4 engagement inhibits adenosine 5′-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism. Mol Med. 18:659–668. 2012.PubMed/NCBI
7	Dai S, Sodhi C, Cetin S, et al: Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness. J Biol Chem. 285:4995–5002. 2010. View Article : Google Scholar : PubMed/NCBI
8	Naugler WE and Karin M: NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev. 18:19–26. 2008. View Article : Google Scholar : PubMed/NCBI
9	Fiuza C, Bustin M, Talwar S, et al: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 101:2652–2660. 2003. View Article : Google Scholar : PubMed/NCBI
10	Poser I, Golob M, Buettner R and Bosserhoff AK: Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol. 23:2991–2998. 2003. View Article : Google Scholar
11	Weng H, Deng Y, Xie Y, Liu H and Gong F: Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors. BMC Cancer. 13:3112013.
12	Frazer IH: Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology. 384:410–414. 2009. View Article : Google Scholar : PubMed/NCBI
13	Scott M, Nakagawa M and Moscicki AB: Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 8:209–220. 2001.PubMed/NCBI
14	Gröne A: Keratinocytes and cytokines. Vet Immunol Immunopathol. 88:1–12. 2002.
15	Locksley RM, Killeen N and Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104:487–501. 2001. View Article : Google Scholar : PubMed/NCBI
16	Vaccari T, Beltrame M, Ferrari S and Bianchi ME: Hmg4, a new member of the Hmg1/2 gene family. Genomics. 49:247–252. 1998. View Article : Google Scholar : PubMed/NCBI
17	Zeh HJ III and Lotze MT: Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother. 28:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
18	Ulloa L and Messmer D: High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 17:189–201. 2006. View Article : Google Scholar : PubMed/NCBI
19	Kim SW, Lim CM, Kim JB, et al: Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotox Res. 20:159–169. 2011. View Article : Google Scholar : PubMed/NCBI
20	Nogueira-Machado JA, Volpe CM, Veloso CA and Chaves MM: HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets. 15:1023–1035. 2011. View Article : Google Scholar
21	Kawai T and Akira S: The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 21:317–337. 2009. View Article : Google Scholar : PubMed/NCBI
22	Hasan UA, Bates E, Takeshita F, et al: TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol. 178:3186–3197. 2007. View Article : Google Scholar : PubMed/NCBI
23	Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723–2735. 1995. View Article : Google Scholar : PubMed/NCBI
24	Ghosh S, May MJ and Kopp EB: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI
25	Ghosh S and Hayden MS: New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 8:837–848. 2008. View Article : Google Scholar : PubMed/NCBI
26	Karin M and Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI